InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: Whalatane post# 408710

Wednesday, 05/10/2023 8:16:50 PM

Wednesday, May 10, 2023 8:16:50 PM

Post# of 425923
The MO canard really hurt Vascepa in the U.S. and Mitigate has a chance to put that to rest for good...Europe is in bad economic shape and is not the answer during the near and medium term...Amarin now needs to turn its attention back to the U.S. and explore whether there is any means available to improve sales and revenues here...AB is more ready to do this job than KM would have been and IMO that is why he was appointed CEO.

Lovaza has been proven to be ineffective in reducing CVD and, in spite of this, it was marketed into becoming a blockbuster...Amarin has been proven effective in reducing CVD and can have the same success.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News